Trial · NCT04331132
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative urine volume output at 48h after randomization | Hour 48 | Urine volume in mL |
| Secondary | Cumulative dose of furosemide at 48h after randomization | Hour 48 | Furosemide dose in mg |
| Secondary | Symptom of dyspnea by 7-point Likert scale at 24h and 48h after randomization | Hour 24, Hour 48 | 3: markedly better, 2: moderately better, 1: minimally better, 0: no change, -1: minimally worse, -2: moderately worse, -3: markedly worse |
| Secondary | Changes in body weight at 24h and 48h after randomization | Hour 24, Hour 48 | weight in gram |
| Secondary | Incidence of clinically relevant worsening renal function at 24h and 48h after randomization | Hour 24, Hour 48 | An increase in serum creatinine ≥ 0.3 mg/dL within 48 hours accompanying doubling the dose of furosemide according to the diuretic treatment protocol |
| Secondary | Changes in serum electrolytes measured at 12h, 24h and 48h after randomization | Hour 12, Hour 24, Hour 48 | Changes in serum sodium (mmol/L), potassium (mmol/L), chloride (mmol/L) |
| Secondary | Changes in urine electrolyte excretion at 6h, 24h and 48h | Hour 6, Hour 24, Hour 48 | Increase in sodium (mmol/L), potassium (mmol/L) and chloride (mmol/L) excretion adjusted for urine creatinine (umol/L) |
| Secondary | Changes in NT-proBNP at 48h after randomization | Hour 0, Hour 48 | Changes in NT-proBNP (pg/mL) |
| Secondary | Changes in mitral e' on echocardiography | Hour 24, Hour 48 | Average of septal e' (cm/s) and lateral e' (cm/s) on tissue doppler imaging in apical 4-chamber view |
| Secondary | Changes in E/e' ratio on echocardiography | Hour 24, Hour 48 | The ratio between mitral E (cm/s) and average e' (cm/s) |
| Secondary | Changes in left atrial volume on echocardiography | Hour 24, Hour 48 | Average of left atrial volumes (ml) by Simpson's rule in apical 4-chamber and 2-chamber view |
| Secondary | Changes in tricuspid regurgitation maximal velocity on echocardiography | Hour 24, Hour 48 | Tricuspid regurgitation maximal velocity (m/s) by continuous wave doppler in apical 4-chamber view |
| Secondary | Changes in inferior vena cava maximal diameter on echocardiography | Hour 24, Hour 48 | Inferior vena cava maximal diameter (mm) in subcostal view |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04331132/registered